Literature DB >> 6371277

Quantitation of beta 2-microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome.

S Zolla-Pazner, D William, W El-Sadr, M Marmor, R Stahl.   

Abstract

Serum samples from 24 patients with acquired immune deficiency syndrome (AIDS) and from 15 patients with an early or milder form of this disease ("suspected AIDS") were found to contain elevated levels of beta 2-microglobulin (beta 2M). Therefore, prospective studies of 40 asymptomatic homosexual men from New York City were undertaken to determine whether quantitation of beta 2M and other immunologic variables was useful in recognizing those in populations at high risk for this disease who have a high probability for experiencing symptoms consistent with AIDS. After 20 to 26 months of follow-up, two of those persons now have AIDS and four have suspected AIDS. All six of these persons had elevated serum beta 2M levels and other immunologic abnormalities when they entered this study. Of those tested, only one other man had an increased level of beta 2M; neither he nor any of the remaining 33 persons in this group developed AIDS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371277

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

1.  Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.

Authors:  J W Mulder; P Krijnen; R A Coutinho; M Bakker; J Goudsmit; J M Lange
Journal:  Genitourin Med       Date:  1991-06

2.  Predicting who will progress to AIDS.

Authors:  A R Moss
Journal:  BMJ       Date:  1988-10-29

3.  Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?

Authors:  M M Chan; J M Campos; S Josephs; N Rifai
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

4.  Estimation of serum beta-2-microglobulin in children with malabsorption disorders syndrome.

Authors:  A Kochańska-Dziurowicz; C Bukowska
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

Review 5.  Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.

Authors:  D Fuchs; A Krämer; G Reibnegger; E R Werner; M P Dierich; J J Goedert; H Wachter
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 6.  Antigen detection for human immunodeficiency virus.

Authors:  D J Harry; M B Jennings; J Yee; J R Carlson
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

Review 7.  T helper cell activation and human retroviral pathogenesis.

Authors:  K F Copeland; J L Heeney
Journal:  Microbiol Rev       Date:  1996-12

8.  Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes.

Authors:  A Kalinkovich; G Livshits; H Engelmann; N Harpaz; R Burstein; M Kaminsky; D Wallach; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease.

Authors:  S Zolla-Pazner; D C Des Jarlais; S R Friedman; T J Spira; M Marmor; R Holzman; D Mildvan; S Yancovitz; U Mathur-Wagh; J Garber
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses.

Authors:  H Mizuma; S Zolla-Pazner; S Litwin; W el-Sadr; S Sharpe; B Zehr; S Weiss; W C Saxinger; M Marmor
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.